Aquestive Therapeutics AQST
NASDAQ AQST
$4.55 +0.11 (+2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Aquestive Therapeutics (AQST) recorded Return on Capital Employed [ROCE] of -43.90% in Q2 2026, up 26.41 percentage points from -70.31% a year earlier and up 3.05 percentage points from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Aquestive Therapeutics reported Return on Capital Employed [ROCE] of -85.28%, down 34.46 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +1.24 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -50.81% in FY2024 (-12.03 pp), -38.79% in FY2023 (+171.51 pp), -210.29% in FY2022 (-124.61 pp) and -85.68% in FY2021 (+0.84 pp).
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last eight quarters, with an average year-over-year change of -8.21 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 244.13 percentage points in Q4 2023, against a drop of 198.56 percentage points in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -46.96% (Q1 2026), -62.12% (Q4 2025) and -54.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Aquestive Therapeutics 571.08 Mn 111.62 Mn 9.80 Mn -43.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.90%
Mar 31, 2026 -46.96%
Dec 31, 2025 -62.12%
Sep 30, 2025 -54.14%
Jun 30, 2025 -70.31%
Mar 31, 2025 -49.30%
Dec 31, 2024 -35.44%
Sep 30, 2024 -21.40%
Jun 30, 2024 -13.85%
Mar 31, 2024 -25.80%
Dec 31, 2023 -37.64%
Sep 30, 2023 -64.11%
Jun 30, 2023 -138.53%
Mar 31, 2023 -196.51%
Dec 31, 2022 -281.76%
Sep 30, 2022 -245.59%
Jun 30, 2022 -157.32%
Mar 31, 2022 -102.32%
Dec 31, 2021 -83.20%
Sep 30, 2021 -94.18%
API Access

Aquestive Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AQST&period=max&api_key=YOUR_API_KEY